1. Elanco to buy Bayer’s animal health business for $7.6 billion — Vanda Pharmaceuticals “perplexed” by FDA rejection of jet lag drug — AstraZeneca's diabetes drug Farxiga helps patients with heart disease and without diabetes in landmark trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

When are they going to clean house with upper management?

Discussion in 'Mission Pharmacal' started by anonymous, Oct 30, 2018 at 10:39 PM.

?

How much time is left?

  1. 6 months

    0 vote(s)
    0.0%
  2. a year or more

    0 vote(s)
    0.0%
  1. anonymous

    anonymous Guest

    How can the family continue to let these incompetent unqualified people run their company into the ground?!? They already did one re-alignment and there is no way Mission can continue to keep the lights on without doing another in the near future. There is no communication, no products in the pipe-line (other than buy & bills wah wah), and no samples? What is the next move?